Chemoinformaics analysis of (25S)-25,27-DIHYDROPHYSALIN A
| Molecular Weight | 528.554 | nRot | 0 |
| Heavy Atom Molecular Weight | 496.298 | nRig | 37 |
| Exact Molecular Weight | 528.2 | nRing | 7 |
| Solubility: LogS | -3.864 | nHRing | 4 |
| Solubility: LogP | 1.543 | No. of Aliphatic Rings | 7 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 70 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
| nHA | 10 | APOL | 76.1174 |
| nHD | 3 | BPOL | 40.7826 |
| QED | 0.379 |
| Synth | 7.26 |
| Natural Product Likeliness | 3.622 |
| NR-PPAR-gamma | 0.55 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.987 |
| Pgp-sub | 0.903 |
| HIA | 0.748 |
| CACO-2 | -5.331 |
| MDCK | 0.0000132 |
| BBB | 0.826 |
| PPB | 0.565815 |
| VDSS | 0.707 |
| FU | 0.399259 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.962 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.785 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.028 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.091 |
| CYP3a4-inh | 0.378 |
| CYP3a4-sub | 0.93 |
| CL | 4.747 |
| T12 | 0.069 |
| hERG | 0.048 |
| Ames | 0.028 |
| ROA | 0.996 |
| SkinSen | 0.018 |
| Carcinogencity | 0.899 |
| EI | 0.007 |
| Respiratory | 0.955 |
| NR-Aromatase | 0.933 |
| Antiviral | Yes |
| Prediction | 0.807335 |